What does Soleno Therapeutics, Inc. do?

Jun 22 2025 06:17 PM IST
share
Share Via
Soleno Therapeutics, Inc. is a micro-cap healthcare company focused on developing and commercializing devices and diagnostics for neonatology. As of March 2025, it reported a net profit loss of $44 million and has a market cap of approximately $3.91 billion.
Overview:
Soleno Therapeutics, Inc. is a healthcare company that develops and commercializes neonatology devices and diagnostics, operating within the Pharmaceuticals & Biotechnology industry and classified as a micro-cap company.

Financial Snapshot:
Most recent Net Profit: -44 Million (Quarterly Results - Mar 2025)
Market-cap: USD 3,910.57 Million (Micro Cap)

Key Metrics:
P/E: NA (Loss Making)
Industry P/E: NA
Dividend Yield: 0.00%
Debt Equity: -1.03
Return on Equity: -82.85%
Price to Book: 16.84

Contact Details:
Address: 1235 Radio Rd Ste 110, REDWOOD CITY CA: 94065-1217
Tel: 1 650 2138444
Fax: 1 302 6555049
Website: http://www.capnia.com
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News